1. Home
  2. LXEO vs SLND Comparison

LXEO vs SLND Comparison

Compare LXEO & SLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXEO
  • SLND
  • Stock Information
  • Founded
  • LXEO 2017
  • SLND 1900
  • Country
  • LXEO United States
  • SLND United States
  • Employees
  • LXEO N/A
  • SLND N/A
  • Industry
  • LXEO
  • SLND Military/Government/Technical
  • Sector
  • LXEO
  • SLND Industrials
  • Exchange
  • LXEO Nasdaq
  • SLND Nasdaq
  • Market Cap
  • LXEO 140.6M
  • SLND 164.0M
  • IPO Year
  • LXEO 2023
  • SLND N/A
  • Fundamental
  • Price
  • LXEO $3.89
  • SLND $3.19
  • Analyst Decision
  • LXEO Strong Buy
  • SLND Buy
  • Analyst Count
  • LXEO 5
  • SLND 2
  • Target Price
  • LXEO $23.80
  • SLND $5.50
  • AVG Volume (30 Days)
  • LXEO 246.3K
  • SLND 23.6K
  • Earning Date
  • LXEO 03-04-2025
  • SLND 03-03-2025
  • Dividend Yield
  • LXEO N/A
  • SLND N/A
  • EPS Growth
  • LXEO N/A
  • SLND N/A
  • EPS
  • LXEO N/A
  • SLND N/A
  • Revenue
  • LXEO N/A
  • SLND $1,029,117,999.00
  • Revenue This Year
  • LXEO N/A
  • SLND N/A
  • Revenue Next Year
  • LXEO N/A
  • SLND $6.18
  • P/E Ratio
  • LXEO N/A
  • SLND N/A
  • Revenue Growth
  • LXEO N/A
  • SLND N/A
  • 52 Week Low
  • LXEO $3.84
  • SLND $1.85
  • 52 Week High
  • LXEO $19.50
  • SLND $6.16
  • Technical
  • Relative Strength Index (RSI)
  • LXEO 33.05
  • SLND 49.31
  • Support Level
  • LXEO $3.84
  • SLND $3.03
  • Resistance Level
  • LXEO $4.72
  • SLND $3.33
  • Average True Range (ATR)
  • LXEO 0.53
  • SLND 0.15
  • MACD
  • LXEO -0.05
  • SLND 0.02
  • Stochastic Oscillator
  • LXEO 2.27
  • SLND 68.68

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.

About SLND Southland Holdings Inc.

Southland Holdings Inc is an infrastructure construction company in North America. The company's infrastructure projects range from water conveyance systems and tunnels to long-span bridges and vertical structures.

Share on Social Networks: